Detalles de la búsqueda
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363833
2.
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 25(6): 744-759, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821083
3.
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Br J Haematol
; 197(5): 590-601, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365860
4.
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.
J Med Internet Res
; 23(12): e27886, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904948
5.
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.
J Med Internet Res
; 22(5): e17018, 2020 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406858
6.
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Haematologica
; 100(4): 525-33, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512643
7.
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry.
Ann Hematol
; 93(10): 1705-15, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24807105
8.
Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Eur J Haematol
; 93(3): 229-38, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24702126
9.
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.
Eur J Haematol
; 92(5): 398-406, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24400940
10.
A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.
Haematologica
; 98(3): 479-86, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22929981
11.
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia.
Vaccines (Basel)
; 11(7)2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515017
12.
The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress.
J Cancer Surviv
; 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37755680
13.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
EClinicalMedicine
; 63: 102167, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680948
14.
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Blood Cancer J
; 12(3): 38, 2022 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264598
15.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240075
16.
A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands.
Leuk Lymphoma
; 62(3): 549-559, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213245
17.
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Blood Cancer J
; 14(1): 3, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177115
18.
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study.
Blood Adv
; 7(17): 4869-4873, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389820
19.
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Lancet Haematol
; 5(8): e359-e367, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30078408
20.
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Blood Cancer J
; 12(9): 125, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055987